Nextcure Inc. (NXTC) NASDAQ
$1.31 (0.13) (-9.03%)
Market Cap: $40.18M
As of 04/25/24 03:59 PM EDT. Market closed.
Nextcure Inc. (NXTC)
NASDAQ
$1.31
(0.13) (-9.03%)
Market Cap: $40.18M
As of 04/25/24 03:59 PM EDT. Market closed.
Add to Portfolio
nextcure, inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. its lead product candidate is nc318, which is in phase 2 clinical trials for the treatment of advanced or metastatic solid tumors. the company is also developing nc410, is a novel ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Michael Richman
Full Time Employees
101
CEO Compensation (Base)
$383,400
CEO Compensation (Total)
$2.50M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Michael Richman
Full Time Employees
101
CEO Compensation (Base)
$383,400
CEO Compensation (Total)
$2.50M
URL
Address
9000 Virginia Manor Rd Ste 200, Maryland, Beltsville, 20705-4214.
PRICE CHART FOR NEXTCURE INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.37
Previous Close
$1.44
Days Range
$1.41 - $1.56
52 week range
$0.98 - $2.57
Volume
156,328
Avg. Volume (30 days)
205,625
Market Cap
$40.18M
Dividend Yield
-
P/E
-
Shares Outstanding
27,903,027
Open
$1.37
Previous Close
$1.44
Days Range
$1.41 - $1.56
52 week range
$0.98 - $2.57
Volume
156,328
Avg. Volume (30 days)
205,625
Market Cap
$40.18M
Dividend Yield
-
P/E
-
Shares Outstanding
27,903,027
FINANCIAL STATEMENTS FOR NEXTCURE INC
LOADING...
INSIDER TRANSACTIONS FOR NEXTCURE INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Heller Kevin N. | Chief Medical Officer | Jul 14, 2020 | Option Exercise | $1.77 | 27,229 | 48,195 | 49,011 | Jul 16, 2020, 04:51 PM |
Liu Linda | SVP, Research | Nov 27, 2019 | Option Exercise | $0.75 | 55,234 | 41,656 | 55,234 | Feb 21, 2020, 04:11 PM |
Sofinnova Venture Partners IX, L.P. | 10% Owner | Nov 15, 2019 | Buy | $36.75 | 150,000 | 5,512,500 | 2,671,856 | Nov 19, 2019, 09:47 PM |
Sofinnova Venture Partners IX, L.P. | 10% Owner | May 13, 2019 | Buy | $15.00 | 400,000 | 6,000,000 | 2,521,856 | May 15, 2019, 05:59 PM |
SHANNON TIMOTHY M | Director | May 13, 2019 | Buy | $15.00 | 50,000 | 750,000 | 2,254,442 | May 13, 2019, 07:33 PM |
Khuong Chau Quang | Director | May 13, 2019 | Buy | $15.00 | 350,000 | 5,250,000 | 2,711,013 | May 13, 2019, 07:32 PM |
Xu Stella | Director | May 13, 2019 | Buy | $15.00 | 125,000 | 1,875,000 | 1,103,570 | May 13, 2019, 07:32 PM |
CANAAN X L.P. | 10% Owner | May 13, 2019 | Buy | $15.00 | 50,000 | 750,000 | 2,254,442 | May 13, 2019, 07:32 PM |
ORBIMED ADVISORS LLC | Director | May 13, 2019 | Buy | $15.00 | 350,000 | 5,250,000 | 2,711,013 | May 13, 2019, 07:32 PM |
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Heller Kevin N. | Chief Medical Officer | 07/14/2020 | 48,195 |
Liu Linda | SVP, Research | 11/27/2019 | 41,656 |
Sofinnova Venture Partners IX, L.P. | 10% Owner | 11/15/2019 | 5,512,500 |
Sofinnova Venture Partners IX, L.P. | 10% Owner | 05/13/2019 | 6,000,000 |
SHANNON TIMOTHY M | Director | 05/13/2019 | 750,000 |
Khuong Chau Quang | Director | 05/13/2019 | 5,250,000 |
Xu Stella | Director | 05/13/2019 | 1,875,000 |
CANAAN X L.P. | 10% Owner | 05/13/2019 | 750,000 |
ORBIMED ADVISORS LLC | Director | 05/13/2019 | 5,250,000 |
FUNDS WITH A POSITION IN NEXTCURE INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 1,268,013 | 0.04% | -53.23% | Other |
BLACKROCK INC. | 890,102 | 0.00003% | -0.89% | Other |
RENAISSANCE TECHNOLOGIES LLC | 293,315 | 0.00052% | 17.23% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 174,707 | 0.00002% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR NEXTCURE INC
STOCK BUYBACKS FOR NEXTCURE INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
0.26%
2Q
03/31/2023
0.46%
3Q
12/31/2022
0.46%
4Q
09/30/2022
0.55%
5Q
06/30/2022
0.57%
6Q
03/31/2022
0.70%
7Q
12/31/2021
0.95%
8Q
09/30/2021
1.04%
9Q
06/30/2021
1.06%
10Q
03/31/2021
1.10%
11Q
12/31/2020
1.26%
12Q
09/30/2020
1.29%
13Q
06/30/2020
1.40%
14Q
03/31/2020
-4.93%
15Q
12/31/2019
77.77%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEXTCURE INC
LOADING...